Interviews

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.

Carlos Aquino, founder and president of PharmaDiversion LLC, discusses timing of inspections from the Drug Enforcement Administration.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses techniques specialty pharmacies can use to improve workflow and clinical activities in therapy management.

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, discusses why she thinks her pharmacy was named best Retail Advantage by Cardinal Health.

Liz Tiefenthaler, president of Pharm Fresh Media, talks about how telling your pharmacy story can improve your pharmacy's brand and nurture patient loyalty.

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can maintain business continuity during a natural disaster or other emergencies.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some ways independent pharmacists could encourage local prescribers to adopt e-prescribing of controlled substances.

Liz Tiefenthaler, president of Pharm Fresh Media, provides some examples of how marketing techniques or outreach efforts differ based on patient demographics.

Carlos Aquino, founder and president of PharmaDiversion LLC, reviews some of the DEA's requirements for handling controlled substances.

Atheer Kaddis, PharmD, senior vice president of Business Development and Sales at Diplomat, discusses retail network services.

Carlos Aquino, founder and president of PharmaDiversion LLC, discusses Drug Enforcement Administration audits of pharmacies.

Kalin M. Clifford, PharmD, BCPS, discusses the benefits and risks of long-term anticoagulant therapy in geriatric patients.

Marc O'Connor, chief operating officer of Curant Health, discusses counseling patients on a therapeutic regimen for IBD.

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses some common problems that arise during a disaster.

Liz Tiefenthaler, president of Pharm Fresh Media, talks about mistakes that some pharmacists make that can disrupt patient loyalty.

Kalin M. Clifford, PharmD, BCPS, discusses when treatment with memantine or cholinesterase should be stopped in patients with dementia.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, discusses challenges pharmacists need to overcome as health care models shift to pay-for-performance reimbursement models.

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, talks about the most common challenges patients face when trying to set up travel immunizations.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the development of medical marijuana within the specialty space.

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about his experience working undercover for the Philadelphia Drug Enforcement Administration task force.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses the alignment between specialty pharmacies and ACOs.

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, talks about the benefits of having a travel section in a pharmacy.

Judy Beizer, PharmD, CBP, FASCP, AGSF, discusses the rewards and challenges of treating geriatric patients.

Judy Beizer, PharmD, CBP, FASCP, AGSF, discusses the drugs that should be used cautiously when treating geriatric patients.

Judy Beizer, PharmD, CBP, FASCP, AGSF, discusses the reasons for the recent changes made to the American Geriatrics Society Beers Criteria.

Kalin M. Clifford, PharmD, BCPS, discusses the pharmacist's role in managing conditions such as dementia or atrial fibrillation in the geriatric population.

Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.